PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31

PetVivo Holdings, Inc.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.75+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $27.79M
P/E (TTM): –
Dividend yield: –

PetVivo Holdings, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31	FY 2016 2016-03-31	FY 2015 2015-03-31	FY 2013 2013-03-31	FY 2012 2012-03-31	FY 2011 2011-03-31	FY 2010 2010-03-31
Revenue	1.14	1.13	0.97	0.92	0.12	0.01	0.00	–	0.00	0.01	0.08	–	–	0	0	–
Cost of Revenue	0.39	0.14	0.10	0.22	0.20	0.01	0.02	0.08	–	–	–	–	–	0	0	–
Gross Profit	0.75	0.99	0.87	0.70	-0.09	0.00	-0.02	-0.08	0.00	0.01	0.08	–	–	0	0	–
Research & Development	1.42	1.58	1.40	1.00	0.47	0.10	0.01	0.20	0.12	0.17	0.17	0.00	–	0	0.16	–
Selling, General & Admin	7.40	7.47	10	8.43	4.50	1.86	1.99	4.29	–	–	–	–	–	–	–	–
Selling & Marketing	3.07	2.64	3.40	3.41	1.35	0.09	0.17	0.04	–	–	–	–	–	–	–	–
General & Administrative	4.33	4.82	6.69	5.02	3.15	1.77	1.82	4.25	2.17	16	3.16	1.20	-0.03	-0.03	0.03	–
Advertising Expenses	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0.00	–
Operating Expenses	9.82	9.05	11	9.43	4.97	1.96	2.00	4.59	2.29	16	3.33	1.20	–	–	–	–
Operating Income	-9.06	-8.06	-11	-8.73	-5.06	-1.96	-2.02	-4.67	-2.29	-16	-3.25	-1.20	–	–	–	–
Interest Expense	0.01	0.01	–	–	–	0.23	0.03	0.08	0.07	0.19	0.27	0.40	–	–	–	–
Interest & Investment Income	0.01	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Non-Operating Income	-1.41	-0.34	-0.33	0.02	0.04	-1.56	-0.07	-0.08	-0.05	-0.13	-1.48	–	0.00	0.00	0.00	–
Asset Impairment Charges	–	–	–	–	–	–	–	–	15	14	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	-0.15	–	–	–	–	–	–	–	–	0.03	–	–	–	–	–	–
Legal Settlements	–	–	-0.18	–	–	–	0.05	–	–	–	–	–	–	–	–	–
Pretax Income	-10	-8.40	-11	-8.72	-5.01	-3.52	-2.08	-4.76	-2.34	-17	-4.73	-1.57	–	–	–	–
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	–	–	0.08	0.10	-0.26	–
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	-2.34	-16	-3.65	-1.57	-0.09	-0.10	-0.26	–
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	0.99	1.08	–	–	–	–	–
Net Income	-10	-8.40	-11	-8.72	-5.01	-3.52	-2.08	-4.76	-2.34	-17	-4.73	-1.57	-0.09	-0.10	-0.26	-0.26
Preferred Dividends	0.40	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	-0.38	-0.41	-0.78	-0.85	-0.57	-0.57	-0.39	-1.04	-0.56	-6.92	-1.84	-0.84	–	0.00	0.00	–
EPS (Diluted)(per share)	-0.38	-0.41	-0.78	-0.85	–	-0.57	-0.39	-1.04	-0.56	-6.92	-1.84	-0.84	–	–	–	–
Shares Outstanding (Basic, Weighted)(shares)	30	20	14	10	8.76	6.20	5.31	4.61	4.24	2.24	1.96	1.90	0.06	0.06	0.05	–
Shares Outstanding (Diluted, Weighted)(shares)	30	20	14	10	8.76	6.20	5.31	4.61	4.24	2.24	1.96	1.90	0.06	0.06	0.05	–
EBITDA	-8.55	-7.88	-10	-8.62	-4.99	-1.87	-1.46	-4.03	-1.64	-16	-2.51	–	–	–	–	–
Net Interest Income	–	-0.36	-0.01	0.02	0.01	-0.23	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 67.0%
Operating margin: -747.0%
Net margin: -827.3%
Return on equity, FY2026: -326.3%

Financial strength

Current ratio: 0.72
Debt to equity: 0.00
Debt to assets: 0.0%
Cash to current liabilities: 9.3%

Valuation

P/E ratio: –
Price to sales: 23.52
Price to book: 20.49
Dividend yield: –